Compare Stocks

→ 2024's Must-Have Guide: Master Crypto Investment Today (From Darwin) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSTG Biostage	$4.45	$4.45	$4.45 ▼ $4.45	$61.78M	-1.02	1,847 shs	N/A
NVCN Neovasc	$30.03	$29.69	$4.59 ▼ $30.07	$82.28M	1.7	56,993 shs	1 shs
PAVM PAVmed	$1.95	$2.20	$1.60 ▼ $9.36	$17.88M	0.85	66,715 shs	11,599 shs
TMDI Titan Medical	$0.14 -26.3%	$0.23	$0.13 ▼ $1.20	$15.67M	2.36	4.83 million shs	7.71 million shs

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSTG Biostage	0.00%	0.00%	0.00%	0.00%	-27.64%
NVCN Neovasc	0.00%	0.00%	0.00%	0.00%	0.00%
PAVM PAVmed	-1.02%	-2.50%	-4.88%	-28.31%	-75.27%
TMDI Titan Medical	0.00%	0.00%	0.00%	0.00%	0.00%

Here’s how to start a “Weekend Side Hustle” from your sofa (Ad)

Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.

Weekend after weekend!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSTG Biostage	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NVCN Neovasc	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	1.6878 of 5 stars	3.0	0.0	0.0	4.3	3.1	0.8	0.0
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSTG Biostage	N/A	N/A	N/A	N/A
NVCN Neovasc	N/A	N/A	N/A	N/A
PAVM PAVmed	2.00	Hold	$21.00	976.92% Upside
TMDI Titan Medical	N/A	N/A	N/A	N/A

Current Analyst Ratings

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSTG Biostage	N/A	N/A	N/A	N/A	($0.26) per share	N/A
NVCN Neovasc	$3.81M	21.60	N/A	N/A	$5.77 per share	5.20
PAVM PAVmed	$2.45M	7.30	N/A	N/A	($3.35) per share	-0.58
TMDI Titan Medical	$20.09M	0.78	N/A	N/A	$0.32 per share	0.44

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSTG Biostage	-$6.07M	-$0.58	N/A	∞	N/A	N/A	N/A	-174.43%	N/A
NVCN Neovasc	-$41.20M	-$15.08	N/A	∞	N/A	-1,082.92%	-127.25%	-80.31%	N/A
PAVM PAVmed	-$64.18M	-$9.33	N/A	∞	N/A	-2,617.25%	N/A	-85.99%	5/21/2024 (Estimated)
TMDI Titan Medical	-$14.86M	-$0.19	N/A	∞	N/A	N/A	-167.03%	-112.15%	N/A

Latest NVCN, TMDI, PAVM, and BSTG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
3/26/2024	Q4 2023	PAVM PAVmed	N/A	-$1.57	-$1.57	-$1.16	N/A	$1.05 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSTG Biostage	N/A	N/A	N/A	N/A	N/A
NVCN Neovasc	N/A	N/A	N/A	N/A	N/A
PAVM PAVmed	N/A	N/A	N/A	N/A	N/A
TMDI Titan Medical	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSTG Biostage	N/A	2.73	2.73
NVCN Neovasc	0.80	2.96	2.85
PAVM PAVmed	N/A	0.45	0.45
TMDI Titan Medical	N/A	1.41	1.41

Ownership

Institutional Ownership

Company	Institutional Ownership
BSTG Biostage	N/A
NVCN Neovasc	1.64%
PAVM PAVmed	19.93%
TMDI Titan Medical	3.55%

Insider Ownership

Company	Insider Ownership
BSTG Biostage	15.30%
NVCN Neovasc	N/A
PAVM PAVmed	12.60%
TMDI Titan Medical	0.02%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BSTG Biostage	7	13.88 million	11.76 million	Not Optionable
NVCN Neovasc	49	2.74 million	N/A	Not Optionable
PAVM PAVmed	107	9.17 million	8.02 million	Optionable
TMDI Titan Medical	49	111.95 million	111.93 million	Not Optionable

NVCN, TMDI, PAVM, and BSTG Headlines

Source	Headline
	Titan Medical Inc.: Titan Medical Reports Fiscal Year 2023 Results finanznachrichten.de - April 1 at 8:49 AM
	Titan Medical signs deal to merge with Conavi Medical msn.com - March 21 at 4:35 AM
	Titan Medical Inc TMDIF morningstar.com - February 27 at 7:19 PM
	Perifery appoints Titan Data Solutions as authorised distributor advanced-television.com - February 13 at 8:31 AM
	Titan Medical Inc (TMD) investing.com - February 13 at 1:56 AM
	Vantage Titan 3T MRI Scanner from Toshiba news-medical.net - January 11 at 8:10 AM
	Attack on Titan: Hajime Isayama Will Create New Titan Story in 2024 comicbook.com - October 3 at 1:41 AM
	Five dead on Titan sub were 'true explorers' - OceanGate bbc.com - September 28 at 10:21 PM
	TMDIF Titan Medical Inc. seekingalpha.com - August 1 at 7:27 PM
	False claim Titan passenger was the vice chairman of the World Economic Forum \| Fact check usatoday.com - July 25 at 1:09 PM
	New details emerge about discovery of Titan submersible debris en.as.com - July 19 at 9:22 AM
	Destiny 2 best Titan build for PvE and PvP videogamer.com - July 18 at 7:32 AM
	Presumed human remains found in Titan sub debris bbc.co.uk - July 14 at 5:59 PM
	The Titan submersible imploded, killing all 5 on board asahi.com - July 9 at 10:09 AM
	Debris and 'Presumed Human Remains' Recovered From Titan Submersible msn.com - June 30 at 7:39 PM
	US Coast Guard says 'presumed human remains' found in wreckage of Titan submersible wbaltv.com - June 30 at 1:27 PM
	Titan Sub Tragedy: "Presumed Human Remains" and Mangled Debris Recovered From Atlantic Ocean eonline.com - June 29 at 9:37 AM
	Possible human remains recovered from Titan wreckage, Coast Guard says msn.com - June 28 at 11:36 PM
	Titan submersible tragedy could lead to lawsuits and regulatory changes, experts say yahoo.com - June 24 at 12:27 PM
	What happens during a catastrophic implosion? Titan submersible occupants likely died instantly winknews.com - June 24 at 1:01 AM
	The science that put the Titan submersible at risk of implosion ktbs.com - June 24 at 1:01 AM
	The Titan submersible: What could have gone wrong? msn.com - June 21 at 2:23 PM
	Report: Banging sounds heard during Titan submersible search, according to internal memo wlox.com - June 21 at 12:43 AM
	Titan Medical Shares Slide as Company Pivots to IP Licensing marketwatch.com - June 20 at 2:37 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Biostage

OTCMKTS:BSTG

Biostage, Inc., a biotechnology company, offers products to cure patients of cancers, injuries, and birth defects of the gastro-intestinal tract and the airways. The company's pipeline includes organ-regeneration technology for the repair or replacement of diseased or damaged organs, as well as product candidates to treat cancer, injury, and birth defects of the bronchus. Its lead product candidate is Biostage Esophageal Implant for the treatment of severe esophageal disease. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2009 and is headquartered in Holliston, Massachusetts.

Neovasc

NASDAQ:NVCN

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

PAVmed

NASDAQ:PAVM

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay. Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.

Titan Medical

NASDAQ:TMDI

Titan Medical, Inc. engages in the research and development of a computer-assisted robotic surgical technology for application in minimally invasive surgery (MIS). Its portfolio, the Enos™ system, is a robotic single access surgery with dual 3D and 2D definition vision systems, multi-articulating instruments, and a surgeon workstation. The company was founded on July 28, 2008 and is headquartered in Toronto, Canada.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial